Clinical Trials
10 trialsNCT03431896 2026-03-12
MED-hATTR
The Cleveland Clinic
Completed
NCT03886155 2021-12-22
CAST
The Cleveland Clinic
Completed
NCT03923920 2021-12-22
ALF
The Cleveland Clinic
Completed
NCT02716103 2021-09-10
MRD
Boston Medical Center
Completed
NCT02555969 2020-08-24
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis
Tufts Medical Center
Completed
NCT02574676 2019-04-09
Quality of Life (QOL) Registry for Patients With AL Amyloidosis
Prothena Biosciences Ltd.
Completed
NCT02033928 2018-02-28
Comprehensive Frailty Assessment
Ohio State University Comprehensive Cancer Center
Completed
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT02257905 2015-07-24
Allo SCT in Amyloidosis Non-interventional Study
European Society for Blood and Marrow Transplantation
Completed
NCT00919139 2015-04-03
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
SWOG Cancer Research Network
Completed